Surgery of the Soft Palate


The soft palate is a subsite of the oropharynx. Its axial plane defines the superior boundary of the oropharynx, incompletely separating it from the nasopharynx above. The soft palate comprises approximately one-third of the palate, with the more anteriorly positioned hard palate making up the remainder; the junction between the hard and soft palates also separates the oral cavity from the more posteriorly located oropharynx. In contrast to the hard palate, the soft palate is a mobile structure that is suspended from the posterior aspect of the hard palate via the palatine aponeurosis. This aponeurosis is formed by the expanded tendon of the tensor veli palatini. The thicker, anterior portion of this tendon constitutes the majority of the anterior soft palate, whereas the posterior aspect of the soft palate is mainly comprised of muscle (levator veli palatine, tensor veli palatini, palatoglossus, palatopharyngeus). At its most posteroinferior extent, the free margin of the soft palate contains a conical muscular projection, the uvula. Functionally, the soft palate is a dynamic structure that is critical for velopharyngeal competence. Elevation of the soft palate puts it into contact with the posterior pharyngeal wall, sealing it off from the nasopharynx (e.g., when swallowing), and its depression puts it in contact with the tongue base, sealing the oral cavity from the nasal passage (e.g., when breathing exclusively through the nose). In this way, function of the soft palate is critical to velopharyngeal competence.

Neoplasms of the soft palate may arise from any of the individual, constituent parts of the soft palate (muscle, lymphatics, mucosa, connective tissue), encompassing a broad variety of benign and malignant tumors ( Table 37.1 ). Importantly, benign tumors of the soft palate are extremely rare, and any soft palate lesion should be considered malignant until proven otherwise. Squamous cell carcinoma is the most common neoplasm of the soft palate, and the oropharynx in general, accounting for more than 90% of all malignant tumors in the oropharynx ( Fig. 37.1 ). Etiologic factors contributing to squamous cell carcinoma are alcohol and tobacco. Although the human papillomavirus (HPV) has more recently been established as an etiologic and positive prognostic factor for oropharyngeal squamous cell carcinoma, a recent review has suggested that significantly less soft palate squamous cell carcinomas are HPV positive than other subsites (22% vs. 70%).

TABLE 37.1
Common Tumors of the Soft Palate
Benign Malignant
Fibroma Adenocarcinoma
Hemangioma Adenoid cystic carcinoma
Lipoma Lymphoma
Papilloma Mucoepidermoid carcinoma
Pleomorphic adenoma Mucosal melanoma
Schwannoma Squamous cell carcinoma

Fig. 37.1, Advanced-stage squamous cell carcinoma of the soft palate.

A tumor of salivary gland origin represents the next most commonly encountered tumor of the soft palate, originating in the many minor salivary glands distributed throughout the soft palate. Although the most common benign salivary gland tumor of the soft palate is pleomorphic adenoma, it is estimated that nearly 50% of minor salivary gland tumors in the oropharynx are malignant. The most common of these malignancies are adenoid cystic carcinoma and mucoepidermoid carcinoma. In contrast to the mucosal disruption caused by typical squamous cell carcinomas, minor salivary gland tumors are frequently submucosal.

Lymphatic drainage of the soft palate is primarily to the superior jugulodigastric chain (level II) with subsequent drainage inferiorly to levels III and IV. Importantly the retropharyngeal lymph nodes also receive significant drainage from the soft palate, with one study demonstrating retropharyngeal node involvement of carcinoma in 56% of cancers of the soft palate. Cancers of the soft palate also have a high incidence of metastases to the cervical lymph nodes, with one study demonstrating that 48% of patients with cancer of the soft palate present with metastases to the neck and another 40% who initially presented with an N0 neck who eventually went on to develop cervical lymph node metastases. Because of this, all patients with clinically negative necks still require treatment with either an elective neck dissection or radiation, with bilateral neck dissection required for lesions involving or approaching the midline.

Key Operative Learning Points

  • 1.

    The soft palate is a dynamic structure whose function is critical for velopharyngeal competence.

  • 2.

    There is a high incidence of cervical lymph node metastasis associated with cancer of the soft palate (particularly with squamous cell carcinoma). Treatment of both necks is recommended for squamous cell cancers involving or approaching the midline.

  • 3.

    Reconstruction of the soft palate is complex, and reconstitution of a functional velopharyngeal sphincter is key.

Preoperative Period

History

  • 1.

    History of present illness

    • a.

      Symptoms range widely from asymptomatic to odynophagia, dysphagia, otalgia, airway compromise, oral bleeding, weight loss, changes in speech, and a mass in the neck.

    • b.

      Early lesions are often found incidentally due to dental examinations, ill-fitting dentures, and office physical examinations but also may present at more advanced stages.

    • c.

      Patients may have hearing loss due to middle ear effusion secondary to Eustachian tube dysfunction.

  • 2.

    Past medical history

    • a.

      Prior history of malignancies and treatment

    • b.

      Anticoagulant medications

  • 3.

    Social history

    • a.

      Tobacco use history (all types)

    • b.

      Alcohol use history

Physical Examination

  • 1.

    All patients should undergo a comprehensive examination of the head and neck.

    • a.

      Thorough inspection and palpation of the oral cavity and oropharynx

    • b.

      Neck: assessment for cervical lymph node metastases

    • c.

      Laryngoscopy/pharyngoscopy: assessment posterior/inferior extent of lesion, evaluation of larynx/hypopharynx, evaluation for second primary malignancy, evaluation of airway patency

    • d.

      Cranial nerve examination: evaluation of palatal elevation (CN X)

  • 2.

    The primary tumor should be evaluated with respect to location and extension into surrounding structures.

    • a.

      Size of the lesion, local extent (e.g., involvement of adjacent subsites), firmness to palpation, mobility, endophytic versus exophytic, oral airway obstruction

    • b.

      A neoplasm isolated to the posterior/nasopharyngeal surface of the soft palate is exceedingly rare.

    • c.

      Mouth opening should be evaluated because trismus and oral airway obstruction by tumor may preclude a transoral resection or intubation.

Imaging

Computed tomography (CT) and magnetic resonance imaging (MRI) are frequently used for delineation of local extent of tumor (T-stage) and evaluation for cervical metastases; (Fluorodoxyglucose-Positon Emission Tomography/Computerized Tomography FDG PET/C) is used to evaluate for distant metastases.

  • 1.

    CT with contrast: primary imaging modality for head and neck cancer; gives excellent delineation of involvement of adjacent bony structures (palate, mandible)

  • 2.

    MRI with contrast: enhanced soft tissue resolution allowing better delineation of depth of invasion and evaluation of perineural invasion. Although MRI has a greater potential for motion artifact, dental artifact is usually significantly less than with CT.

  • 3.

    FDG PET/CT: improved sensitivity over CT or MRI alone in detecting metastases greater than 5 mm. The negative predictive value of PET/CT is nearly 100% for second primary tumors and metastatic disease.

Indications

  • 1.

    Early-stage (T1-T2) squamous cell carcinoma with minimal involvement of soft palate musculature

  • 2.

    Advanced (T3-T4) cancer of salivary gland origin

  • 3.

    Salvage surgery for persistent/recurrent cancers (salvage is typically successful in only ⅓ of patients)

Contraindications

  • 1.

    Advanced (T3-T4) lesions requiring resection of a significant portion of the soft palate musculature (exception: patients who are not candidates for or who have already received definitive radiation)

  • 2.

    Patients with distant metastases or large/unresectable cervical lymph node metastases

  • 3.

    Proximity to large vessels to or involvement of primary tumor (i.e., medialized course of carotid artery or tumor adjacent to carotid artery)

  • 4.

    Patients with significant trismus or oral contractures limiting access for a transoral resection (transcervical resection may still be possible)

  • 5.

    Patients medically unfit to undergo general anesthesia (rare)

Preoperative Preparation

  • 1.

    Biopsy of the lesion should be performed for adequate diagnosis prior to any definitive resection.

  • 2.

    Evaluation for metastasis should be completed preoperatively.

  • 3.

    Discussion of surgery with a complete explanation of risks/benefits/alternatives

    • a.

      Risks: bleeding, infection, need for additional surgery and/or adjunctive treatments, velopharyngeal incompetence

    • b.

      Benefits: tumor excision, pathologic staging, possibility of avoiding radiation therapy and/or chemotherapy in some cases

    • c.

      Alternatives: Radiation ± chemotherapy depending on tumor stage. Not effective in tumors of salivary gland origin.

  • 4.

    Patients should be aware of the possibility and expected duration of a tracheostomy and/or placement of a feeding tube.

  • 5.

    Patient should be seen in consultation with a Maxillofacial Prosthodontist with possible fabrication of a prosthesis.

Operative Period

You're Reading a Preview

Become a Clinical Tree membership for Full access and enjoy Unlimited articles

Become membership

If you are a member. Log in here